Tin, a $20 offer to buy the company would not be a low ball offer at this point considering our stock value has eroded to $4. It would represent an attractive 400% premium. I am hopeful Lombardo is negotiating a sale in that realm. Given the incompetence, greed and missteps we have seen from ADXS management over the last several years, I just don't see it to benefit anyone (except management) to continue operating the company as an independent stand-alone entity at this juncture. It's in the best interest of ADXS investors and patients to sell the company now IMO. Hoping for the best.
News 
Market Data 
Discover 
